Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) Short Interest Down 88.9% in February

Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) was the recipient of a large drop in short interest in the month of February. As of February 28th, there was short interest totalling 100 shares, a drop of 88.9% from the February 13th total of 900 shares. Based on an average daily volume of 2,400 shares, the short-interest ratio is presently 0.0 days.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Trading Up 0.6 %

Shares of NASDAQ:HROWM traded up $0.17 on Thursday, hitting $26.75. The company had a trading volume of 1,406 shares, compared to its average volume of 2,768. Harrow Health, Inc. 11.875% Senior Notes due 2027 has a 1 year low of $25.30 and a 1 year high of $27.70. The firm’s 50-day simple moving average is $26.60 and its two-hundred day simple moving average is $26.44.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Wednesday, January 15th were given a dividend of $0.7422 per share. The ex-dividend date of this dividend was Wednesday, January 15th. This represents a $2.97 dividend on an annualized basis and a yield of 11.10%.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Company Profile

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.